According to T2 Biosystems 's latest financial reports the company's current EPS (TTM) is -$286.90. In 2022 the company made an earnings per share (EPS) of -$1,143 a decrease over its 2021 EPS that were of -$30.42.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$286.90 | -74.9% |
2022 | -$1,143 | 3657.07% |
2021 | -$30.42 | -28.16% |
2020 | -$42.35 | -63.02% |
2019 | -$114.50 | 3.62% |
2018 | -$110.50 | -34.42% |
2017 | -$168.50 | -20.52% |
2016 | -$212.00 | -3.64% |
2015 | -$220.00 | -4.41% |
2014 | -$230.16 | 37.82% |
2013 | -$167.00 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Aldeyra Therapeutics
ALDX | -$0.89 | -99.69% | ๐บ๐ธ USA |
CareDx CDNA | -$1.56 | -99.46% | ๐บ๐ธ USA |